Spentys
Spentys provides an end-to-end, AI-powered software platform for the digital design and manufacturing of custom-fit orthotics and prosthetics.
- CEO / Founder
- Louis-Philippe Broze
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $9.1M
- Latest Round
- Seed
- Key Investors
- Invest.BW, welovefounders, SambrInvest, SRIB, Finnance.brussels, Innovation Fund
Technology & Products
Key Products
["Spentys 3D Design Automation Software Platform"]
Technological Advantage
The core advantage is the platform's ability to drastically reduce the time and cost of producing custom orthopedic devices. This allows healthcare providers to scale production, improve patient comfort with lightweight and waterproof designs, and ensure consistent, high-quality clinical outcomes.
Differentiation
Value Proposition
To enable mass customization of orthopedic devices by automating the design and manufacturing workflow, significantly reducing manual labor, improving accuracy, and decreasing patient delivery times.
How They Differentiate
Spentys differentiates itself by focusing on a holistic, user-friendly software platform that automates the entire workflow, rather than just offering a 3D printing service or a single-point solution. This empowers the healthcare providers themselves to produce the devices in-house or through a network.
Market & Competition
Target Customers
Hospitals, orthopedic clinics, and Orthotics & Prosthetics (O&P) professionals.
Industry Verticals
["Healthcare","Medical Devices","Orthopedics"]
Competitors
ActivArmor; Axial3D; Ortho Baltic
Growth & Milestones
Major Milestones
["Co-founder Florian De Boeck named in Forbes 30 Under 30 Europe 2023.","Secured a €2.5M grant from the European Innovation Council (EIC) Accelerator in 2023.","Established key partnerships with industry leaders like HP, BASF, and Materialise to advance digital orthopedics."]
Notable Customers
Case study with HP indicates a focus on clinics utilizing HP's Multi Jet Fusion technology.